Harrow Health (HROW) Misses Q4 EPS by 23c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. EXPE
5. ARM
6. QCOM
7. DDOG
8. CPAY
9. CHYM
10. W

Go back to Harrow Health (HROW) Misses Q4 EPS by 23c

Harrow Health Announces Fourth Quarter and Year-End 2021 Financial Results

March 10, 2022 4:01 PM EST

Sixth Consecutive Quarter of Record Revenues 

Highlights for Fourth Quarter 2021:

Record revenues of $20.2 million, a 38% increase compared with $14.6 million for the prioryear quarter; Gross profit was a record $15.1 million, a 42% increase compared with $10.7 million for the prioryear quarter; Gross margin increased to 75% compared with 73% in the prior-year quarter; FDA acceptance of AMP-100 NDA and assignment of PDUFA target date of October 16, 2022; Commissions from DEXYCU® sales increased to $1.0 million on record unit volumes; and Cash and cash equivalents was $42.2 million at December 31,... More